FI943019A0 - Terapeuttisia aineita - Google Patents

Terapeuttisia aineita

Info

Publication number
FI943019A0
FI943019A0 FI943019A FI943019A FI943019A0 FI 943019 A0 FI943019 A0 FI 943019A0 FI 943019 A FI943019 A FI 943019A FI 943019 A FI943019 A FI 943019A FI 943019 A0 FI943019 A0 FI 943019A0
Authority
FI
Finland
Prior art keywords
alkyl
represents hydrogen
halo
alkoxy
pct
Prior art date
Application number
FI943019A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943019A (fi
Inventor
Bernard John Armitage
John Gareth Bowen
Malcolm John Crossley
Ian Michael Hunneyball
Bruce William Leslie
Thomas Kerr Miller
Michael Spowage
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of FI943019A publication Critical patent/FI943019A/fi
Publication of FI943019A0 publication Critical patent/FI943019A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI943019A 1991-12-23 1994-06-22 Terapeuttisia aineita FI943019A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (fr) 1991-12-23 1992-12-12 Derives de naphtyridine antirhumatismaux
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
FI943019A FI943019A (fi) 1994-06-22
FI943019A0 true FI943019A0 (fi) 1994-06-22

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943019A FI943019A0 (fi) 1991-12-23 1994-06-22 Terapeuttisia aineita

Country Status (22)

Country Link
US (1) US5464781A (fr)
EP (1) EP0618916B1 (fr)
JP (1) JP2527917B2 (fr)
CN (1) CN1096784A (fr)
AT (1) ATE171452T1 (fr)
AU (1) AU656832B2 (fr)
BG (1) BG98813A (fr)
CA (1) CA2125858A1 (fr)
CZ (1) CZ153594A3 (fr)
DE (1) DE69227125T2 (fr)
FI (1) FI943019A0 (fr)
GB (1) GB9127252D0 (fr)
HR (1) HRP921455A2 (fr)
HU (1) HUT66971A (fr)
IL (1) IL104169A0 (fr)
IN (1) IN174405B (fr)
MX (1) MX9207494A (fr)
NO (1) NO942376L (fr)
NZ (1) NZ246156A (fr)
SI (1) SI9200408A (fr)
SK (1) SK75094A3 (fr)
WO (1) WO1993013097A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
KR100567649B1 (ko) 1996-09-25 2006-04-05 아스트라제네카 유케이 리미티드 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
EP1192151B1 (fr) 1999-07-09 2007-11-07 Glaxo Group Limited Anilino-quinazolines comme inhibiteurs de la proteine tyrosine kinase
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
NZ521421A (en) 2000-04-07 2004-09-24 Astrazeneca Ab Quinazoline compounds
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006074147A2 (fr) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Composes et utilisation therapeutique associee
CN1984660B (zh) 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
MXPA06007242A (es) 2003-12-23 2006-08-18 Pfizer Nuevos derivados de quinolina.
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP2345652A1 (fr) 2005-12-21 2011-07-20 Abbott Laboratories Composées antivirales
WO2007076035A2 (fr) * 2005-12-21 2007-07-05 Abbott Laboratories Composes antiviraux
NZ569817A (en) * 2005-12-21 2011-10-28 Abbott Lab Anti-viral compounds
EP1971611B1 (fr) 2005-12-21 2012-10-10 Abbott Laboratories Composes anti-viraux
TWI392676B (zh) * 2005-12-21 2013-04-11 Abbott Lab 抗病毒化合物、其製備方法及用途
WO2008133753A2 (fr) 2006-12-20 2008-11-06 Abbott Laboratories Composés antiviraux
CA2727103A1 (fr) * 2008-07-03 2010-01-07 Merck Patent Gmbh Naphtyridinones en tant qu'inhibiteurs d'aurora kinase
EP2401275B1 (fr) 2009-02-24 2013-07-24 Respiratorius AB Dérivés de naphthyridine à activité bronchodilatatoire
WO2011063398A1 (fr) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphes et sels d'un inhibiteur de kinase
PE20130211A1 (es) 2010-04-02 2013-03-22 Senomyx Inc Modificador del sabor dulce

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (fr) * 1985-05-17 1988-11-09 Univ Australian Composes antipaludiques.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc p−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
EP0302303A3 (fr) * 1987-07-22 1989-05-24 Schering Corporation Composés bicycliques, leur utilisation pharmaceutique, leur préparation et intermédiaires pour leur préparation
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 1,8−ナフチリジン−2−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
IN174405B (fr) 1994-11-26
CN1096784A (zh) 1994-12-28
FI943019A (fi) 1994-06-22
CZ153594A3 (en) 1995-02-15
ATE171452T1 (de) 1998-10-15
SI9200408A (en) 1993-09-30
DE69227125D1 (de) 1998-10-29
NZ246156A (en) 1996-01-26
GB9127252D0 (en) 1992-02-19
SK75094A3 (en) 1995-04-12
DE69227125T2 (de) 1999-02-18
HUT66971A (en) 1995-01-30
EP0618916A1 (fr) 1994-10-12
IL104169A0 (en) 1993-05-13
JPH07502280A (ja) 1995-03-09
JP2527917B2 (ja) 1996-08-28
WO1993013097A1 (fr) 1993-07-08
AU656832B2 (en) 1995-02-16
CA2125858A1 (fr) 1993-07-08
HU9401877D0 (en) 1994-09-28
NO942376D0 (fr) 1994-06-22
EP0618916B1 (fr) 1998-09-23
BG98813A (bg) 1995-05-31
MX9207494A (es) 1993-07-01
NO942376L (no) 1994-06-22
HRP921455A2 (en) 1994-12-31
US5464781A (en) 1995-11-07
AU3158793A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
FI943019A (fi) Terapeuttisia aineita
HU9600278D0 (en) Remedy for nervous diseases
GR3034769T3 (en) Triazole antifungal agents.
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
IL134894A (en) 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them
GB9305641D0 (en) Therapeutic agents
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
NO942374L (no) Terapeutiske midler
SE0102058D0 (sv) New Salts II
JO1754B1 (en) Therapeutic agents
ZA952403B (en) New 2,4-diphosphonoglutaric acid derivatives processes for their production and pharmaceutical agents containing these compounds
AR018002A1 (es) Composicion farmaceutica que comprende un anticonvulsivo y una resina de intercambio ionico para el tratamiento de la epilepsia, compuestos, uso de lapirrolidona polivinilica y proceso para preparar la composicion

Legal Events

Date Code Title Description
FD Application lapsed